The Thin Film Drugs Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Thin Film Drugs Market is estimated to be USD 17.41 billion in 2017 and predicted to rise to USD 26.79 billion by 2022 with a CAGR of 9%. The market is segmented by Product (Oral Thin Film (Sublingual Film and Fully Dissolving Dental/Buccal Film), and Transdermal Thin Film), Disease Indication (Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting), and Distribution Channel (Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The growing demand for efficient drug delivery systems has amplified the uptake of thin film drugs due to their efficiency and effectiveness. The convenience of transportation and storage has encouraged patients to opt for these drugs. Thin film drugs also permit precise dosages to accomplish desired outcomes and thereby aid the market growth. The growing investments in research and development of newer polymeric thin films as a method of drug deliver has also invigorated the market growth. Thin film drugs are poised to gain attention in the healthcare industry as eliminate the drawbacks associated with conventional forms of dosages such as inconvenience of administration, lower bioavailability, and patient non-compliance among others.
The global Thin Film Drugs market is segmented on the basis of Product, Disease Indication and Distribution Channel. On the basis of Product, the market is segmented into Oral Thin Film, and Transdermal Thin Film. The Oral Thin Film sub segment is further segmented into Sublingual Film and Fully Dissolving Dental/Buccal Film. In 2017, the oral thin film sub segment held the largest share of the Product market segment followed by transdermal thin film. On the basis of Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting. On the basis of Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce.
On the basis of geography, the Thin Film Drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for the largest share of the Thin Film Drugs market owing to factors such as advancements in pharmaceutical research coupled with extensive investments in research and development. Moreover, a steadily rising demand of novel drug delivery is further expected to aid the growth of the regional market.
The market is dominated by companies like Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co. Ltd., Indivior Plc., MonoSol Rx, IntelGenx Corp., ZIM Laboratories Limited, and IntelGenx Corp.
Browse through the full report at https://www.marketdataforecast.com/market-reports/thin-film-drugs-market-6411/ and checkout our recent reports in the Pharmaceuticals https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.